Madurai News

Tinnitus Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Auris Medical, Sound Pharmaceuticals, Otonomy, Knopp Biosciences, Otologic Pharmaceutics and Others

 Breaking News
  • No posts were found

Tinnitus Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Auris Medical, Sound Pharmaceuticals, Otonomy, Knopp Biosciences, Otologic Pharmaceutics and Others

May 13
10:35 2021
Tinnitus Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Auris Medical, Sound Pharmaceuticals, Otonomy, Knopp Biosciences, Otologic Pharmaceutics and Others

Tinnitus Pipeline

Tinnitus is commonly described as a ringing in the ears, but it also can sound like roaring, clicking, hissing, or buzzing. It may be soft or loud, high pitched or low pitched. Tinnitus represents one of the most common and distressing otologic problems, and it causes various somatic and psychological disorders that interfere with the quality of life. The most common associated symptoms or subjective discomforts involve concentration difficulties, insomnia, and decreased speech discrimination. Tinnitus does not represent a disease itself but instead is a symptom of a variety of underlying diseases. Otologic causes include noise-induced hearing loss, presbycusis, otosclerosis, otitis, impacted cerumen, sudden deafness, Meniere’s disease, and other causes of hearing loss.

“DelveInsight’s, “Tinnitus Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 9+ pipeline drugs in Tinnitus pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Some of Tinnitus Companies are:

  • Auris Medical
  • Sound Pharmaceuticals
  • Otonomy
  • Knopp Biosciences
  • Otologic Pharmaceutics
  • Decibel Therapeutics
  • And Many Others

 

Request for free Sample Report: https://www.delveinsight.com/sample-request/tinnitus-pipeline-insight

 

DelveInsight’s Tinnitus report covers around 9+ products under different phases of clinical development like:

  • Late stage products (Phase III)
  • Mid-stage products (Phase II)
  • Early-stage product (Phase I) along with the details of
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates
  • Route of Administration

 

Some of Tinnitus Therapies are:

  • AM-101
  • Ebselen
  • OTO-313
  • AM 102
  • Research programme: potassium channel activators
  • NHPN-1010
  • DB-XX5
  • And Many Others

 

Request for free Sample Report: https://www.delveinsight.com/sample-request/tinnitus-pipeline-insight

 

Current Tinnitus Treatment Scenario and Tinnitus Emerging Therapies:

  • How many companies are developing Tinnitus drugs?
  • How many Tinnitus drugs are developed by each company?
  • How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Tinnitus?
  • What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Tinnitus therapeutics?
  • What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Tinnitus and their status?
  • What are the key designations that have been granted to the emerging drugs?

 

Request for free Sample Report: https://www.delveinsight.com/sample-request/tinnitus-pipeline-insight

 

Table of Contents:

Introduction

Executive Summary

Tinnitus: Overview

Pipeline Therapeutics

• Comparative Analysis

Therapeutic Assessment

Tinnitus – DelveInsight’s Analytical Perspective

In-depth Commercial Assessment

• Tinnitus companies’ collaborations, Licensing, Acquisition -Deal Value Trends

Tinnitus Collaboration Deals

Late Stage Products (Preregistration)

• Comparative Analysis

Drug name: Company name

Drug profiles in the detailed report…..

Late Stage Products (Phase III)

• Comparative Analysis

AM-101: Auris Medical

Drug profiles in the detailed report…..

Mid Stage Products (Phase II)

• Comparative Analysis

OTO-313: Otonomy

Drug profiles in the detailed report…..

Preclinical and Discovery Stage Products

• Comparative Analysis

Research programme: potassium channel activators – Knopp Biosciences

Drug profiles in the detailed report…..

Inactive Products

• Comparative Analysis

Tinnitus Key Companies

Tinnitus Key Products

Tinnitus- Unmet Needs

Tinnitus- Market Drivers and Barriers

Tinnitus- Future Perspectives and Conclusion

Tinnitus Analyst Views

Tinnitus Key Companies

Appendix

Request for Detailed TOC: https://www.delveinsight.com/sample-request/tinnitus-pipeline-insight

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/tinnitus-pipeline-insight

Recent Posts

Drilling Fluids Market To Generate Significant Revenue Due To Rising Momentum in Offshore Decommissioning Services in European And Middle-East Region Till 2025 | Million Insights

Read Full Article

Categories